The IPO Window Is Reopening—but Market Plumbing Will Set the Terms
Why a deeper pipeline, lockup supply and overnight safeguards matter more than headline deal counts
The short version
The US IPO market is no longer just waiting for a single “window.” It is showing the early shape of a broader reopening: the SEC counted 99 IPOs raising more than $22 billion in the first quarter of 2026, versus 84 IPOs and more than $11.8 billion in the first quarter of 2025. Follow-on registered offerings also increased to 264 deals raising more than $44.2 billion, from 250 deals raising more than $40.4 billion a year earlier.[1]
That improvement matters because issuance is a liquidity event, not only a fundraising event. New shares add supply, lockups delay part of that supply, underwriters stabilize early trading, and exchange rules determine how prices behave when orders become one-sided. The base case is constructive but conditional: the pipeline can broaden if pricing remains disciplined and investors continue to distinguish durable cash flows from thematic enthusiasm.
A reopening with a concentrated center of gravity
The first-half backdrop was unusually strong by recent standards. EY reports that US IPO proceeds surged in the first half, with 12 deals above $1 billion versus four in the comparable prior-year period; it also says 62 US IPOs raised more than $50 million through June 30, compared with 34 in the same period of 2025.[2]
The composition is as important as the count. AI and AI-adjacent businesses, aerospace, defense and biotech have been prominent, while enterprise software has remained more muted as investors reassess how artificial intelligence changes software economics. EY’s framing is useful: the market has demand, but sustaining a durable cycle still requires rational pricing, broader sector participation and continued earnings quality.[2]
The latest filing flow points in the same direction. Renaissance Capital reported on September 4 that eight IPOs and three SPACs filed during the prior week, including SB Energy, an AI-infrastructure power developer, and Oura, a consumer health technology company. It also identified estimated deal sizes of $5 billion for SB Energy, $2.5 billion for Oura and $800 million for Accelevation—but those are estimates, not final terms, and can change before pricing.[3]
Why issuance is a market-structure story
A headline deal count can hide three different supply questions:
| Question | What it measures | Why it matters |
|---|---|---|
| How many shares are actually in the public float? | Tradable shares at listing, excluding restricted or closely held stock | A small float can amplify both opening gains and drawdowns |
| When can additional holders sell? | Lockup releases, insider sales and registration rights | Delayed supply can turn a quiet listing into a later liquidity test |
| How much capital is being raised versus sold by existing holders? | Primary proceeds versus secondary shares | Primary issuance funds the company; secondary supply changes ownership and exit liquidity |
The practical implication is that the prospectus—not the marketing headline—contains the market’s operating instructions. Readers should check the initial float, greenshoe or over-allotment provisions, lockup exceptions, resale registration language, major-holder concentration and whether the company expects additional capital raises.
Lockups are particularly easy to misread. A standard-looking period does not guarantee a single release date: agreements can contain early-release triggers, partial unlocks, affiliate restrictions and exceptions for employee plans or strategic transactions. The relevant question is not simply “when does the lockup expire?” but “how much incremental supply could become eligible to trade, and how does that compare with the existing float and average daily volume?”
Liquidity can improve—and still be fragile
More issuance can deepen markets over time, but newly public companies often begin with incomplete price discovery. A high first-day return may reflect limited float, a strong allocation imbalance or a shortage of natural sellers; it is not by itself evidence of durable demand. Conversely, a weak debut can reflect a crowded calendar or cautious underwriting rather than a definitive judgment on the business.
The same distinction applies to follow-ons and buybacks. Follow-on offerings increase supply and can fund growth or repair a balance sheet, but they may pressure trading when investors perceive dilution or urgency. Buybacks can reduce available shares and provide a source of demand, yet their effect depends on authorization, execution and whether repurchases offset employee compensation or other issuance. The market-plumbing lens is therefore about net share supply, not the label attached to a transaction.
Volatility controls are part of the reopening
The SEC approved an amendment to the national market system’s volatility plan in August 2026 concerning temporary price-band protections in overnight trading.[4] The development is relevant to new listings and thinly traded securities because overnight liquidity is typically less continuous and more fragmented than regular-session trading.
Safeguards can reduce disorderly prints, but they do not eliminate risk. A price band may pause or constrain trading while information continues to arrive; when trading resumes, the underlying imbalance can remain. For IPO investors, the useful question is whether a listing has enough two-sided liquidity to absorb news without relying on the protection as a substitute for depth.
What the current evidence does—and does not—say
Observed: IPO and follow-on activity were higher year over year in Q1; first-half proceeds were strong; and the late-August filing pipeline featured several large AI-infrastructure and consumer technology names.[1][2][3]
Reasonable inference: Capital formation conditions are more open than they were during the recent subdued period, but issuance remains concentrated in themes with strong investor attention. That concentration raises the importance of pricing discipline and post-listing liquidity.
Still unknown: Whether the pipeline will convert into priced deals, how much final supply will be primary versus secondary, and whether post-IPO performance will broaden beyond AI-linked issuance. Filing estimates are not deal terms, and an announced calendar is not a guarantee of completion.
What to watch next
- Conversion from filing to pricing. Track amended prospectuses, expected price ranges and final share counts rather than treating a registration statement as a completed offering.
- Float relative to expected trading volume. A narrow float can exaggerate early price moves; compare the tradable share count with realistic daily turnover.
- Lockup mechanics. Map partial releases, early-release conditions and affiliate blocks. The calendar matters, but the size of eligible supply matters more.
- Primary versus secondary mix. Primary proceeds indicate new capital entering the company; secondary shares can satisfy existing holders without adding corporate cash.
- Sector breadth. A healthier reopening would extend beyond AI infrastructure into consumer, healthcare, industrial and financial issuers without requiring the market to abandon quality standards.
- Volatility outside regular hours. Watch how overnight price-band protections interact with news, fragmented liquidity and the first weeks of trading for new listings.
The balanced conclusion is that the IPO window appears wider, but not yet self-sustaining. The next phase will be judged less by the number of prospectuses filed than by whether new supply can trade with credible depth, whether lockups release without disorder, and whether capital formation broadens beyond a small set of high-attention themes.